Phoenix Molecular Designs has been granted the Canadian patent titled "Methods of Inhibiting RSK for Treatment of Breast Cancer."

Aug. 15
2019

August 15, 2019 - The Canadian Intellectual Property Office has granted us our Method of Use Patent for inhibiting RSK for the treatment of breast cancer.

Link to the patent here